Evidence map›Paper›PMID 37474530›Full record

ArticleScientific data2023

The daily updated Dutch national database on COVID-19 epidemiology, vaccination and sewage surveillance.

E L P E Geubbels, J A Backer, F Bakhshi-Raiez, R F H J van der Beek, B H B van Benthem, J van den Boogaard, E H Broekman, D A Dongelmans, D Eggink, R D van Gaalen and 19 more

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys, 2016 to 2017 and 2020 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 2 institutions in 1 country.

E L P E GeubbelsCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. eveline.geubbels@rivm.nl.ORCID 0000-0002-9702-5460
J A BackerCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
F Bakhshi-RaiezNational Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands.
R F H J van der BeekCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
B H B van BenthemCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
J van den BoogaardCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
E H BroekmanGGD GHOR Nederland, Utrecht, the Netherlands.
D A DongelmansNational Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands.
D EgginkCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
R D van GaalenCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.ORCID 0000-0002-5107-8073
A van GageldonkCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
S HahnéCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
K HajjiCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
A HofhuisCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
A J van HoekCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
M N KooijmanCentre of Information Services and CIO office, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
A KronemanCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
W LodderCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
M van RooijenCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.ORCID 0000-0002-3839-1487
W RoordaGGD GHOR Nederland, Utrecht, the Netherlands.
N SmorenburgCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
F ZwagemakerCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
National sewage surveillance group
RIVM COVID-19 epidemiology, surveillance team
N F de KeizerNational Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands.ORCID 0000-0002-6651-1730
I van WalleCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.ORCID 0000-0003-3857-9057
A M de Roda HusmanCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.ORCID 0000-0001-9651-0504
C RuijsGGD GHOR Nederland, Utrecht, the Netherlands.
S van den HofCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. susan.van.den.hof@rivm.nl.ORCID 0000-0002-2968-9652
National Institute for Public Health and the Environment · NLAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Dutch national open database on COVID-19 has been incrementally expanded since its start on 30 April 2020 and now includes datasets on symptoms, tests performed, individual-level positive cases and deaths, cases and deaths among vulnerable populations, settings of transmission, hospital and ICU admissions, SARS-CoV-2 variants, viral loads in sewage, vaccinations and the effective reproduction number. This data is collected by municipal health services, laboratories, hospitals, sewage treatment plants, vaccination providers and citizens and is cleaned, analysed and published, mostly daily, by the National Institute for Public Health and the Environment (RIVM) in the Netherlands, using automated scripts. Because these datasets cover the key aspects of the pandemic and are available at detailed geographical level, they are essential to gain a thorough understanding of the past and current COVID-19 epidemiology in the Netherlands. Future purposes of these datasets include country-level comparative analysis on the effect of non-pharmaceutical interventions against COVID-19 in different contexts, such as different cultural values or levels of socio-economic disparity, and studies on COVID-19 and weather factors.

Indexed as

COVID-19HumansNetherlandsSARS-CoV-2SewageVaccinationWastewater-Based Epidemiological MonitoringSewage

Identifiers

PMID37474530
PMCPMC10359398
OpenAlexW4384924845

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.